接受新辅助化疗的晚期卵巢癌患者的手术复杂性评分与腹腔镜的作用
这项多中心研究纳入282例接受新辅助化疗及间歇性肿瘤细胞减灭术的晚期上皮性卵巢癌患者,评估手术复杂性评分(SCS)与微创手术(MIS)的作用。多因素分析显示年龄≥75岁、残留病灶>1 cm及SCS≥3与更差疾病特异性总生存(DSS)显著相关;R0队列中SCS未显著预测DSS。51例腹腔镜间歇性肿瘤细胞减灭术中24例(47%)中转开腹,MIS似乎安全可行且肿瘤细胞减灭率可接受。
要点
- 年龄≥75岁、SCS≥3、残留病灶>1 cm是新辅助化疗后间歇性肿瘤细胞减灭术患者DSS更差的预测因素。
- 以R0定义满意减灭时,SCS未显著预测DSS。
- 51例腹腔镜间歇性肿瘤细胞减灭术中24例(47%)中转开腹,MIS似乎安全可行。
核心结论
- 在接受新辅助化疗的晚期上皮性卵巢癌女性中,年龄≥75岁、SCS≥3及间歇性肿瘤细胞减灭术时残留病灶>1 cm是更差生存的预测因素。
- MIS似乎安全可行,且满意肿瘤细胞减灭率可接受。
研究设计与样本
- 多中心研究,纳入接受新辅助化疗与间歇性肿瘤细胞减灭术的晚期上皮性卵巢癌患者282例。
- 根据间歇性肿瘤细胞减灭术所见分配SCS,采用Cox比例风险回归模型进行单因素和多因素生存分析。
主要发现
- 282例中80.5%为高级别浆液性组织学,54.6%年龄<75岁(中位63.9岁;范围34.1-84.8岁)。
- 约84%达到满意肿瘤细胞减灭(61% R0;23%残留<1 cm)。
- 多因素分析(模型同时纳入并发症与ASA评分)中,年龄≥75岁(p≤0.001)、残留病灶>1 cm(p=0.03)及SCS≥3(p=0.04)显著预测更差DSS。
- 以R0定义满意减灭时,仅年龄≥75岁(p<0.001)与DSS降低显著相关;R0队列中SCS未显著预测DSS。
- 以≤1 cm定义满意的亚组分析中,较高SCS与死亡风险增加1.6倍相关(p=0.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate surgical complexity scores (SCS) and minimally invasive surgery (MIS) at interval debulking surgery (IDS) in advanced epithelial ovarian cancer (EOC) patients receiving neoadjuvant chemotherapy (NACT). METHODS: A multi-institutional study of NACT with IDS for advanced EOC was conducted. Demographic data were abstracted and SCS assigned based on IDS findings. Disease-specific overall survival (DSS) was defined as the time from completion of adjuvant chemotherapy to death due to disease. Cox proportional hazards regression models were used for univariate and multivariate survival analyses. RESULTS: 282 patients were identified; 80.5% had high-grade serous histology and 54.6% were <75 (median 63.9; range 34.1-84.8). Approximately 84% were optimally cytoreduced (61% R0; 23% <1 cm). In multivariate analyses, age 75+ (p ≤ 0.001), residual disease (>1 cm; p = 0.03), and SCS ≥ 3 (p = 0.04) were significantly predictive of worse DSS when morbidity and ASA score were also in the model. When optimally debulked was defined as R0, only age 75+ (<0.001) was significantly associated with decreased DSS. In the R0 cohort, SCS did not significantly predict DSS. However, subset analysis defining optimal ≤1 cm, revealed higher SCS was associated with a 1.6-fold increased risk of death (p = 0.02). Fifty-one patients underwent laparoscopic IDS. Twenty-four (47%) were converted to laparotomy to achieve optimal debulking in 21 patients (87.5%); while 25 had laparoscopic optimal cytoreduction (19/25 [76%] R0). CONCLUSIONS: In women with advanced EOC treated with NACT, older age, SCS ≥ 3, and residual disease >1 cm at IDS were predictors of worse survival. MIS appears safe and feasible with acceptable optimal cytoreduction rates.
引用
- Davidson BA, Broadwater G, Crim A, et al. Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2018. PMID: 30558972. doi:10.1016/j.ygyno.2018.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。